» Articles » PMID: 32955133

Structure of the Plasmodium Falciparum PfSERA5 Pseudo-zymogen

Overview
Journal Protein Sci
Specialty Biochemistry
Date 2020 Sep 21
PMID 32955133
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

PfSERA5, a significantly abundant protein present within the parasitophorous vacuole (PV) and essential for normal growth during the blood-stage life cycle of the malaria parasite Plasmodium falciparum, displays structural similarity to many other cysteine proteases. However, PfSERA5 does not exhibit any detectable protease activity and therefore the role of the PfSERA5 papain-like domain (PfSERA5E), thought to remain bound to its cognate prodomain, remains unknown. In this study, we present a revised structure of the central PfSERA5E domain at a resolution of 1.2 Å, and the first structure of the "zymogen" of this papain-like domain including its cognate prodomain (PfSERA5PE) to 2.2 Å resolution. PfSERA5PE is somewhat structurally similar to that of other known proenzymes, retaining the conserved overall folding and orientation of the prodomain through, and occluding, the archetypal papain-like catalytic triad "active-site" cleft, in the same reverse direction as conventional prodomains. Our findings are congruent with previously identified structures of PfSERA5E and of similar "zymogens" and provide a foundation for further investigation into the function of PfSERA5.

Citing Articles

Targeting the proteome and organelles for potential antimalarial drug candidates.

Abugri J, Ayariga J, Sunwiale S, Wezena C, Gyamfi J, Adu-Frimpong M Heliyon. 2022; 8(8):e10390.

PMID: 36033316 PMC: 9398786. DOI: 10.1016/j.heliyon.2022.e10390.


Autocatalytic activation of a malarial egress protease is druggable and requires a protein cofactor.

Tan M, Koussis K, Withers-Martinez C, Howell S, Thomas J, Hackett F EMBO J. 2021; 40(11):e107226.

PMID: 33932049 PMC: 8167364. DOI: 10.15252/embj.2020107226.


Structure of the Plasmodium falciparum PfSERA5 pseudo-zymogen.

Smith N, Clarke O, Lee M, Hodder A, Smith B Protein Sci. 2020; 29(11):2245-2258.

PMID: 32955133 PMC: 7586913. DOI: 10.1002/pro.3956.

References
1.
Verma S, Dixit R, Pandey K . Cysteine Proteases: Modes of Activation and Future Prospects as Pharmacological Targets. Front Pharmacol. 2016; 7:107. PMC: 4842899. DOI: 10.3389/fphar.2016.00107. View

2.
Yeoh S, ODonnell R, Koussis K, Dluzewski A, Ansell K, Osborne S . Subcellular discharge of a serine protease mediates release of invasive malaria parasites from host erythrocytes. Cell. 2007; 131(6):1072-83. DOI: 10.1016/j.cell.2007.10.049. View

3.
Liebschner D, Afonine P, Baker M, Bunkoczi G, Chen V, Croll T . Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr D Struct Biol. 2019; 75(Pt 10):861-877. PMC: 6778852. DOI: 10.1107/S2059798319011471. View

4.
Olotu A, Fegan G, Wambua J, Nyangweso G, Leach A, Lievens M . Seven-Year Efficacy of RTS,S/AS01 Malaria Vaccine among Young African Children. N Engl J Med. 2016; 374(26):2519-29. PMC: 4962898. DOI: 10.1056/NEJMoa1515257. View

5.
Lee B, Richards F . The interpretation of protein structures: estimation of static accessibility. J Mol Biol. 1971; 55(3):379-400. DOI: 10.1016/0022-2836(71)90324-x. View